Is the Indian version of pomalidomide cheaper?

Pomalidomide (Pomalidomide) is an important immunomodulatory drug used in the treatment of multiple myeloma and other diseases. It has been officially launched in China and has been included in the medical insurance catalog, which greatly facilitates patients' regular medication channels. However, although patients can enjoy a certain degree of reimbursement discounts after being included in medical insurance, the price of the original drug is still high. For patients who need to take the drug for a long time, the financial pressure is still considerable, especially in areas with low or limited medical insurance reimbursement ratios. Patients still have to bear part of the high costs.

In comparison, the price of generic versions of pomalidomide produced in countries such as India and Laos is relatively more affordable, especially the Laos version, which is priced at approximately 300 multiple RMB per box, which is far lower than the retail price of original drugs before domestic medical insurance. This price difference has caused many patients to turn their attention to overseas generic drugs to ease the burden of medication. On the premise of ensuring reliable sources of drugs, Indian or Lao versions of generic drugs have become an important alternative for some patients with limited economic conditions because of their lower prices.

However, it should be noted that overseas generic drugs are different from domestic original drugs in terms of quality supervision, drug consistency evaluation and safety of use. Although most generic drugs in countries such as India and Laos follow internationally accepted generic standards, there are still legal and regulatory gray areas in the use of products that have not been registered and approved in China. When considering the use of overseas drugs, patients should fully weigh the efficacy, safety and legality, and consult professional doctors to avoid the risks of medication caused by purchasing them on their own.

Overall, the Indian or Lao versions of pomalidomide are indeed more advantageous in terms of price, and are an alternative worth paying attention to, especially for patients with limited financial conditions who need to take the drug for a long time. However, patients should pay attention to the formality of drug purchase channels and the safety of medication. If they can make reasonable choices under the guidance of doctors, overseas generic drugs can alleviate the economic burden to a certain extent and provide support for long-term disease management.

Reference materials:https://www.drugs.com/